COMPANY
MATRIX PHARMACORP PRIVATE LTD
MATRIX PHARMACORP PRIVATE LTD: API manufacturer for Abaloparatide, Icatibant, Leuprolide, Octreotide, Plecanatide, as stated by public registers.
API MANUFACTURER
Filed a drug master file with FDA for the active ingredient.
| Abaloparatide | DMF 36475, type II, active, submitted 2021-12-03 Regulator FDA drug master file list |
|---|---|
| Icatibant | DMF 31260, type II, active, submitted 2016-12-29 Regulator FDA drug master file list |
| Leuprolide | DMF 32295, type II, active, submitted 2017-12-19 Regulator FDA drug master file list |
| Octreotide | DMF 27729, type II, active, submitted 2013-12-20 Regulator FDA drug master file list |
| Plecanatide | DMF 34227, type II, active, submitted 2019-11-27 Regulator FDA drug master file list |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.